Cargando…
Real-world data analysis of patients with cancer of unknown primary
Cancer of unknown primary (CUP) is a heterogeneous malignancy in which the primary site of the tumor cannot be identified through standard work-up. The survival outcome of CUP is generally poor, and there is no consensus for treatment. Here, we comprehensively analyzed the real-world data of 218 pat...
Autores principales: | Kang, Sora, Jeong, Jae Ho, Yoon, Shinkyo, Yoo, Changhoon, Kim, Kyu-pyo, Cho, Hyungwoo, Ryoo, Baek-Yeol, Jung, Jinhong, Kim, Jeong Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630084/ https://www.ncbi.nlm.nih.gov/pubmed/34845302 http://dx.doi.org/10.1038/s41598-021-02543-1 |
Ejemplares similares
-
Radiation therapy for recurrent extrahepatic bile duct cancer
por: Koh, Minji, et al.
Publicado: (2021) -
Imatinib Plasma Monitoring-Guided Dose Modification for Managing Imatinib-Related Toxicities in Gastrointestinal Stromal Tumor Patients
por: Yoon, Shinkyo, et al.
Publicado: (2013) -
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
por: Bang, Kyunghye, et al.
Publicado: (2021) -
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
por: Hyung, Jaewon, et al.
Publicado: (2019) -
Real-world outcomes of adjuvant gemcitabine versus
gemcitabine plus capecitabine for resected pancreatic ductal
adenocarcinoma
por: Kang, Sora, et al.
Publicado: (2022)